Ancriviroc
Ancriviroc (SCH-351125) is a potent and orally bioavailable small molecule antagonist of the CCR5 chemokine receptor with a Kd of 9.27 nM. It blocks HIV-1 entry via the CCR5 co-receptor and is a valuable research tool for studying viral infection mechanisms in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
370893-06-4
Product Name Alternative
CHEMBL336672, CHEMBL-336672, CHEMBL 336672, Ancriviroc, AC1NUILE, [3H]ancriviroc, HIV, HIV Protease, HIVProtease, SCH 351125, SCH351125, SCH-351125, Schering C
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.31% (May vary between batches)
Solubility
DMSO:50 mg/mL (89.68 mM)
Smiles
CCO\N=C (\C1CCN (CC1) C1 (C) CCN (CC1) C (=O) c1c (C) ccn (=O) c1C) c1ccc (Br) cc1
Molecular Formula
C28H37BrN4O3
Molecular Weight
557.533
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
